About SCRI

about SCRI

The Singapore Clinical Research Institute (SCRI) is a national academic research organisation dedicated to enhancing the standards of human clinical research.

As a wholly-owned subsidiary of MOH Holdings, we strive to improve patient care through the design and conduct of cutting-edge clinical research. The highly experienced scientists and operations team at SCRI works closely with our partners, including leading pharmaceutical, medical devices and biotech, as well as academic Investigators.

News and Workshops

SCRI 3rd Annual Scientific Symposium

Upcoming SCRI 3rd Annual Scientific Symposium The Singapore Clinical Research Institute (SCRI) will be hosting its 3rd Annual Scientific Symposium.  This year, the event will be held at the Conrad Centennial Singapore on Tuesday, 29 August 2017, 8.00 a.m.    The Symposium will begin with the Launch Ceremony of a National Learning and Development Programme Framework for Clinical Research Coordinators, followed by a […]

Presentation of the Results of the pivotal Asia-Pacific multi-center liver cancer trial SIRveNIB at Annual Meeting of the American Society of Clinical Oncology (ASCO)

The multi-center SIRveNIB (AHCC protocol 06) trial led by the National Cancer Center Singapore (NCCS) and the Singapore Clinical Research Institute (SCRI) closed in May 2016.  At its close  the trial had enrolled 360 patients from 27 centers in 11 member countries of the Asia-Pacific Hepatocellular Carcinoma (AHCC) Trials Group. This pivotal phase III trial […]

Our Collaborators

ah
ah
ah
ah
ah
ah